Geneservice Forms Alliance with VWR International Europe
News Feb 27, 2006
Geneservice Ltd has announced a five-year strategic alliance with VWRI for sales representation of Companies contract research platforms.
Customers in Europe, USA and the UK will now be able to access genotyping, gene expression and DNA handling capabilities at Geneservice via their local VWR specialist service representative.
VWR’s sales and marketing operation currently serves over 250,000 customers with an extensive worldwide specialist sales network
Geneservice claims that, this strategically important agreement, the first since the management buyout of MRC Geneservice in 2005, is further evidence of Geneservice’s commitment to providing the latest discovery contract research platforms to a growing customer base.
Tom Weaver, CEO at Geneservice commented, "Our new alliance with VWRI is strategically important for us. It significantly increases our geographical coverage and makes our leading contract research platforms available to more researchers worldwide."
"We are delighted to have been selected by VWR to be one of the first companies to be included in the VWR Bioscience programme."
The alliance is designed to offer a balance and fit between Geneservice’s expertise in genomic contract research and VWR’s marketing capabilities, global market strength and representation.
Geneservice customers will benefit from the proximity with their local VWR specialist service representative, and will have direct access to technology and a team of scientists with extensive project management experience at Geneservice.
Working with VWR will substantially increase Geneservice’s exposure by promoting its expert contract research program and customer service to academic, clinical, government, biotech and pharma labs world-wide.
Dr. Weaver also highlighted that, "Working with VWR in setting up this alliance has been terrific, and it has been more like partnering with another small start-up company instead of what is in reality a very large corporation."
"This has facilitated our ability to move quickly and effectively, and I believe this says a lot about VWR Biosciences innovative management team."
"Even though selling services will be a new challenge for VWR reps, so far there has been excellent communication with our scientists and shared vision on how to make this venture a success and swiftly grow the business."
Zishan Haroon, CEO of VWR Biosciences commented, "Geneservice is an industry leading genomic service provider and we are pleased to have been chosen by them for this important alliance."
"The VWRI biosciences team is looking forward to presenting the extensive range of contract research to our growing customer base."
In a new study in cells, University of Illinois researchers have adapted CRISPR gene-editing technology to cause the cell’s internal machinery to skip over a small portion of a gene when transcribing it into a template for protein building. This gives researchers a way not only to eliminate a mutated gene sequence, but to influence how the gene is expressed and regulated.
Researchers published today a detailed description of the complete genome of bread wheat, the world's most widely-cultivated crop. This work will pave the way for the production of wheat varieties better adapted to climate challenges, with higher yields, enhanced nutritional quality and improved sustainability.